Hasan “Lucas” Seyhun, 45, of Miami, Florida, pleaded guilty yesterday to conspiracy to commit healthcare fraud for his role ...

Rice farmers and quarantine inspectors may soon have a powerful new weapon against one of the world’s most destructive rice diseases. A research team in China has developed two rapid diagnostic p ...

Countable Labs announces Ancora assays for molecular testing of hematologic malignancy, marking the company's entry into clinical markets.

The Democratic Republic of the Congo is currently experiencing a Bundibugyo virus (BDBV) outbreak. BDBV can cause severe ...

Hasan Seyhun pleaded guilty in a $500 million COVID-19 testing fraud scheme after allegedly helping submit millions of dollars falsely.

(Nasdaq: BDSX), a leading diagnostics solutions company, today announced strategic progress in two collaborative programs for tumor-informed and tumor-naïve Molecular Residual Disease (MRD) solutions ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAmini, a compact automated sample preparation system designed to give research laboratories a time-saving and ...

It was a mixed week for ASX healthcare, with Paradigm stumbling in phase III, Telix striking a $3.3bn deal and ... Read More ...

Smith, has found a new technique to diagnose infections of the central nervous system, such as meningitis and encephalitis, ...

New research shows a blood test can detect returning breast cancer months to years before scans or symptoms appear.

A Florida man pleaded guilty for his role in a COVID-era healthcare fraud scheme, the U.S. Attorney's Office for the Eastern District of Michigan announced Thursday. Hasan "Lucas" Seyhun, 45, of Miami ...

In September 2026, AI company Anthropic announced the launch of its life sciences research group, revealing that its ...